Exponent (EXPO) reported fiscal Q2 earnings late Thursday of $0.60 per diluted share, up from $0.52 a year earlier.
Analysts polled by FactSet expected $0.55.
Revenue for the three months ended July 3 was $171.6 million, up from $142 million a year earlier.
Revenue before reimbursements for the quarter was $148.9 million, up from $132.9 million a year ago.
Three analysts expected $145 million.
For Q3, the company expects revenue before reimbursements growth of 8% to 10%.
For the full-year 2026, the company now expects revenue before reimbursements growth of 9% to 10%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.